| Issue |
Section |
Title |
File |
| No 1 (2017) |
Articles |
PROPHYLAXIS OF EARLY REPRODUCTIVE LOSSES |
|
| No 9 (2017) |
Articles |
Pathogenetic mechanisms of placental insufficiency and preeclampsia |
|
| No 11 (2018) |
Articles |
Predicting impairment of pre-lactation transformation and preventing lactogenesis failure in metabolic syndrome |
|
| No 6 (2019) |
Articles |
Catamenial pneumotorax as a manifestation of pulmonary forms of endometriosis |
|
| No 1 (2020) |
Articles |
Efficiency of gestational and perinatal pathology prevention with a cytokine-like peptide in frequently recurring herpes at the pregravid stage |
|
| No 9 (2019) |
Articles |
Management of puerperal inferior vena cava thrombosis after massive hemorrhage due to placenta increta |
|
| No 2 (2020) |
Articles |
Clinical significance of the immunohistochemical profile of ovarian endometrioid cysts |
|
| No 3 (2021) |
Articles |
Identity of preeclampsia and metabolic syndrome clinical manifestations: searching for substantiation |
|
| No 4 (2021) |
Articles |
Favorable outcome of managing a pregnant woman with epidermolytic drug syndrome |
|
| No 7 (2021) |
Articles |
Optimizing management strategy in infertile patients with ovarian endometriosis |
|
| No 9 (2022) |
Articles |
The role of fetal gender in the pathogenesis of gestational diabetes mellitus and obstetric complications |
|
| No 5 (2022) |
Articles |
Favorable maternal and perinatal outcomes of pregnancy in a COVID-19 patient with total lung damage |
|
| No 1 (2022) |
Articles |
Role of insulin resistance in the mechanisms of adaptation and development of female reproductive system disease |
|
| No 4 (2022) |
Articles |
Preeclampsia as a separate gestational clinical and pathogenetic form of insulin resistance syndrome |
|
| No 2 (2022) |
Articles |
Role of insulin resistance in the mechanisms of adaptation and development of disease in postpartum and early neonatal periods |
|
| No 3 (2023) |
Clinical Notes |
Intra-abdominal hemorrhage in a pregnant woman as a manifestation of endometrioid disease |
|
| No 9 (2020) |
Articles |
Pregnancy is a natural model of metabolic syndrome: results of a dynamic study of physiological gestation |
|
| No 2 (2023) |
Original Articles |
Association between new coronavirus infection and fetal growth restriction |
|
| No 9 (2023) |
Original Articles |
Clinical and pathogenetic rationale for two-stage prevention of preeclampsia in high-risk women using an insulin sensitizer for preconception preparation |
|
| No 11 (2023) |
Exchange of Experience |
Complex therapy of recurrent vulvovaginal candidiasis in pregnancy |
|
| No 4 (2024) |
Reviews |
The concept of epigenetic modifications in fetal metabolic programming |
|
| No 4 (2024) |
Original Articles |
Rationale for preoperative treatment of advanced-stage endometrial ovarian cysts in infertile women |
|
| No 5 (2024) |
Original Articles |
Factors of energy metabolism in fetal growth restriction |
|
| No 10 (2024) |
Original Articles |
Pathogenetic features of the preclinical stage ofgestational complications in women with endometriosis |
|
